245 related articles for article (PubMed ID: 28248938)
1. Bracing for the biosimilar wave.
Mullard A
Nat Rev Drug Discov; 2017 Mar; 16(3):152-154. PubMed ID: 28248938
[No Abstract] [Full Text] [Related]
2. Regulatory watch: Innovation in biologic new molecular entities: 1986-2014.
Miller KL; Lanthier M
Nat Rev Drug Discov; 2015 Feb; 14(2):83. PubMed ID: 25633785
[No Abstract] [Full Text] [Related]
3. Patent watch: Have the biosimilar floodgates been opened in the United States?
Brinckerhoff CC; Schorr K
Nat Rev Drug Discov; 2015 May; 14(5):303-4. PubMed ID: 25924576
[No Abstract] [Full Text] [Related]
4. Assessing biosimilarity and interchangeability of biosimilar products.
Chow SC
Stat Med; 2013 Feb; 32(3):361-3. PubMed ID: 23307569
[No Abstract] [Full Text] [Related]
5. Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS.
Kim J; Ross JS; Kapczynski A
JAMA; 2018 Jan; 319(1):21-22. PubMed ID: 29117365
[No Abstract] [Full Text] [Related]
6. First biosimilar drug approved for sale in the United States.
Hede K
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142444
[No Abstract] [Full Text] [Related]
7. A cheat sheet to navigate the complex maze of exclusivities in the United States.
Peng B; Tomas MC
Pharm Pat Anal; 2014 Jul; 3(4):339-43. PubMed ID: 25291306
[No Abstract] [Full Text] [Related]
8. Considerations in the early development of biosimilar products.
Li EC; Abbas R; Jacobs IA; Yin D
Drug Discov Today; 2015 May; 20 Suppl 2():1-9. PubMed ID: 25572407
[TBL] [Abstract][Full Text] [Related]
9. Biosimilars: where we were and where we are.
Challand R; Gorham H; Constant J
J Biopharm Stat; 2014; 24(6):1154-64. PubMed ID: 25036475
[TBL] [Abstract][Full Text] [Related]
10. Biosimilars in the Caribbean--key considerations.
Cox SD
West Indian Med J; 2012 Dec; 61(9):849-52. PubMed ID: 24020222
[No Abstract] [Full Text] [Related]
11. Biosimilar Makers Hope Court Starts 6-Month Wait Sooner.
Silverman E
Manag Care; 2017 Mar; 26(3):31. PubMed ID: 28510518
[TBL] [Abstract][Full Text] [Related]
12. Biosimilars battle rages on, Amgen fights both sides.
Senior M
Nat Biotechnol; 2013 Apr; 31(4):269-70. PubMed ID: 23563402
[No Abstract] [Full Text] [Related]
13. Biosimilars: how similar?
Strand V; Cronstein B
Intern Med J; 2014 Mar; 44(3):218-23. PubMed ID: 24118772
[TBL] [Abstract][Full Text] [Related]
14. Biosimilars.
Bagel J
J Drugs Dermatol; 2014 Jul; 13(7):788-90. PubMed ID: 25007360
[No Abstract] [Full Text] [Related]
15. The 21st Century Cures Act--Will It Take Us Back in Time?
Avorn J; Kesselheim AS
N Engl J Med; 2015 Jun; 372(26):2473-5. PubMed ID: 26039522
[No Abstract] [Full Text] [Related]
16. Patent litigation could make 2017 no 'dancing' matter.
Reinke T
Manag Care; 2016 Dec; 25(12):23-28. PubMed ID: 28121555
[TBL] [Abstract][Full Text] [Related]
17. Transforming Drug Development in Heart Failure: Navigating the Regulatory Crossroads.
Vaduganathan M; Butler J; Gheorghiade M
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27707750
[No Abstract] [Full Text] [Related]
18. Using Data Exclusivity Grants to Incentivize Cumulative Innovation of Biologics' Manufacturing Processes.
Levi EL
Am Univ Law Rev; 2017; 66(3):911-70. PubMed ID: 28233970
[TBL] [Abstract][Full Text] [Related]
19. Maintaining 'standards' for biosimilar monoclonal antibodies.
Prior S; Metcalfe C; Hufton SE; Wadhwa M; Schneider CK; Burns C
Nat Biotechnol; 2021 Mar; 39(3):276-280. PubMed ID: 33664522
[No Abstract] [Full Text] [Related]
20. BIOSIMILAR DRUGS ARE NOT GENERICS.
Zangeneh F; Dolinar R
Endocr Pract; 2016 Jan; 22(1):6-7. PubMed ID: 26731083
[No Abstract] [Full Text] [Related]
[Next] [New Search]